Correlation Engine 2.0
Clear Search sequence regions

  • ACSL4 (2)
  • acyl coa (1)
  • ARHGAP6 (15)
  • arhgap6 protein, human (1)
  • breast cancer (6)
  • cancer (4)
  • cell death (3)
  • CHAC1 (2)
  • death rate (1)
  • female (1)
  • GPX4 (2)
  • GTPase (3)
  • humans (1)
  • investigates (1)
  • kinases (2)
  • lipids (5)
  • mice (2)
  • mitogen (2)
  • oxygen (5)
  • p38 (3)
  • p38 MAPK (4)
  • patient (1)
  • protein human (2)
  • protein kinases (2)
  • PTGS2 (2)
  • ROCK1 (4)
  • ROCK1 protein (1)
  • rt pcr (1)
  • SLC7A11 (2)
  • species (5)
  • tumor breast (2)
  • Sizes of these terms reflect their relevance to your search.

    Ferroptosis, a distinct iron-dependent form of regulated cell death, is induced by severe lipid peroxidation due to reactive oxygen species (ROS) generation. Breast cancer patient survival is correlated with the tumor-suppressing properties of Rho guanosine triphosphatase hydrolase enzyme (GTPase)-activating protein 6 (ARHGAP6). This study investigates the impact and mechanisms of ARHGAP6 on ferroptosis in breast cancer. Using quantitative RT-PCR, Western blotting, and immunofluorescence staining, ARHGAP6 expression was detected in a gene expression dataset, cancer tissue samples, and cells. ARHGAP6 was overexpressed or silenced in breast cancer cell lines. Cell proliferation was measured using 5-ethynyl-2-deoxyuridine (EdU) assay, and cell death rate was determined using LDH cytotoxicity assay. As indicators of ferroptosis, Fe2+ ion content, lipid ROS, glutathione peroxidase 4 (GPX4), ChaC glutathione specific gamma-glutamylcyclotransferase 1 (CHAC1), prostaglandin-endoperoxide synthase 2 (PTGS2), solute carrier family 7 member 11 (SLC7A11), and acyl-CoA synthetase long chain family member 4 (ACSL4) levels were evaluated. ARHGAP6 was obviously downregulated in cancer tissues and cells. ARHGAP6 overexpression decreased cell proliferation, elevated cell death and lipid ROS, decreased GPX4 and SLC7A11, increased PTGS2, ACSL4, and CHAC1, and inhibited RhoA/ROCK1 and p38 MAPK signaling in cancer cells. ARHGAP6 knockdown exerted opposite effects to those of ARHGAP6 overexpression. p38 signaling suppression reversed the effect of ARHGAP6 knockdown on ferroptosis, while RhoA/ROCK1 signaling inhibition compromised the effect of ARHGAP6 on p38 MAPK signaling. In mice models, ARHGAP6 together with the ferroptosis inducer RSL3 cooperatively enhanced ferroptosis and inhibited tumor growth of cancer cells. ARHGAP6 mRNA level was positively correlated with that of ferroptosis indicators in tumor tissues. This study revealed that ARHGAP6 inhibited tumor growth of breast cancer by inducing ferroptosis via RhoA/ROCK1/p38 MAPK signaling. Integrating ARHGAP6 with ferroptosis-inducing agents may be a promising therapeutic strategy for breast cancer treatment. © 2024 The Author(s). Published by IMR Press.


    Xiaoqing Chen, Jing Zhu, Xiangzhi Li, Jintao Chen, Zhisheng Zhou, Xulong Fan, Ruijian Liang, Haiyan Liu, Dajiang Zhu. ARHGAP6 Suppresses Breast Cancer Tumor Growth by Promoting Ferroptosis via RhoA-ROCK1-p38 MAPK Signaling. Frontiers in bioscience (Landmark edition). 2024 Jan 12;29(1):6

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 38287795

    View Full Text